The demand for Lipid-Lowering Agents in Mongolia has been increasing steadily over the past few years.
Customer preferences: Mongolian consumers are becoming more health-conscious and are increasingly concerned about their cholesterol levels. As a result, there has been a growing demand for Lipid-Lowering Agents in the country. Consumers are also more aware of the various options available to them and are willing to pay a premium for high-quality products.
Trends in the market: The Lipid-Lowering Agents market in Mongolia is expected to continue to grow in the coming years. The market is being driven by factors such as an aging population, an increase in lifestyle diseases, and rising disposable incomes. The market is also benefiting from the growing trend towards self-medication, which is driving sales of over-the-counter Lipid-Lowering Agents.
Local special circumstances: Mongolia is a relatively small market for Lipid-Lowering Agents, but it is growing rapidly. The country has a population of just over three million people, but it is a relatively wealthy country with a growing middle class. This means that there is a significant market for high-quality Lipid-Lowering Agents, and many consumers are willing to pay a premium for these products.
Underlying macroeconomic factors: Mongolia's economy is growing rapidly, driven by its vast mineral resources. The country has a relatively low level of debt and a stable political environment, which has helped to attract foreign investment. This has led to rising disposable incomes, which in turn is driving demand for Lipid-Lowering Agents. At the same time, the country's aging population is also contributing to the growth of the market, as older people are more likely to require Lipid-Lowering Agents to manage their cholesterol levels. Overall, the Lipid-Lowering Agents market in Mongolia is expected to continue to grow in the coming years, driven by these underlying macroeconomic factors.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
